Tactoset was launched in the United States, a surgically delivered therapy for insufficiency fractures.
510(k) clearance received for the company’s first suture anchors comprised of biocomposite material bTCP/PLGA2.
FDA clearance received for Synd-EZ Kits for ankle syndesmosis repair2.
ATLAS (Anatomic Thumb Ligament Arthroplasty System), a more anatomical and less invasive arthroplasty solution to treat arthritis of the CMC joint (thumb), gained 501(k) clearance2.